Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature

Background: High-titer convalescent plasma given early for COVID-19 may decrease progression into a severe infection. Here, we reported a study of serial antibody measurements in patients who received CP at our center and performed a systematic review of randomized trials on CP. Methods: Our center...

Descripción completa

Detalles Bibliográficos
Autores principales: Whang, Sonia N., Shah, Vivek D., Pu, Lu, Sheth, Parthiv, Lucas, Gina N., Lee, Joanne, Lee, Michael, Lacy, Curtis, Duerksen-Hughes, Penelope J., Filippov, Valeri, Lee, David J. H., Veltman, Jennifer, Maken, Kanwaljeet, Reeves, Mark E., Stevens, Wesley Tait, Herrmann, Paul, Cao, Huynh, Lau, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503397/
https://www.ncbi.nlm.nih.gov/pubmed/36145390
http://dx.doi.org/10.3390/pathogens11090958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503397/
https://www.ncbi.nlm.nih.gov/pubmed/36145390
http://dx.doi.org/10.3390/pathogens11090958

Ejemplares similares